Skip to main content
main-content

Video+

Video commentaries

08-21-2019 | Diet | Video | Article

Are these popular diets safe for your patients with type 2 diabetes?

WATCH | Egg diets? Alkaline diets? Raspberry ketones? Pam Dyson and Liz Morris discuss how to handle your patients' questions about these dietary approaches and more.

08-14-2019 | Diet | Video | Article

Which diets can I safely recommend to patients with type 2 diabetes?

WATCH | Research Dietitian Pam Dyson and General Practitioner Liz Morris discuss evidence-based dietary recommendations for the management of type 2 diabetes.

08-14-2019 | Diet | Video | Article

Which diets can I safely recommend to patients with type 2 diabetes?

WATCH | Research Dietitian Pam Dyson and General Practitioner Liz Morris discuss the findings from the DiRECT trial, including the real-world implications for recommending a diet that can put type 2 diabetes into remission (2:18).

Ask the expert

08-21-2019 | Diet | Video | Article

Are these popular diets safe for your patients with type 2 diabetes?

WATCH | Egg diets? Alkaline diets? Raspberry ketones? Pam Dyson and Liz Morris discuss how to handle your patients' questions about these dietary approaches and more.

08-14-2019 | Diet | Video | Article

Which diets can I safely recommend to patients with type 2 diabetes?

WATCH | Research Dietitian Pam Dyson and General Practitioner Liz Morris discuss evidence-based dietary recommendations for the management of type 2 diabetes.

08-14-2019 | Diet | Video | Article

Which diets can I safely recommend to patients with type 2 diabetes?

WATCH | Research Dietitian Pam Dyson and General Practitioner Liz Morris discuss the findings from the DiRECT trial, including the real-world implications for recommending a diet that can put type 2 diabetes into remission (2:18).

07-02-2019 | Dulaglutide | Podcast | Article

REWIND, DECLARE, and high-risk diabetes patients

How will the findings of the REWIND trial and the DECLARE-TIMI 58 renal outcomes analysis affect treatment decisions for high-risk diabetes patients without overt cardiovascular disease? medwireNews asks Kamlesh Khunti.

04-17-2019 | Nephropathy | Podcast | Article

Nephrologist expert commentary: The CREDENCE trial

Consultant nephrologist Andrew Frankel tells medwireNews about the rationale and key findings of the CREDENCE trial, and discusses the potential benefits of SGLT2 inhibitors beyond type 2 diabetes (9:45).

04-17-2019 | Nephropathy | Podcast | Article

Primary care expert commentary: The CREDENCE trial

General practitioner Kevin Fernando talks to medwireNews about the importance of the CREDENCE trial from a primary care perspective (4:43).

04-15-2019 | Nephropathy | Podcast | Article

Researcher comment: The CREDENCE trial

Lead investigator Vlado Perkovic talks about the main findings from the CREDENCE trial – demonstrating that canagliflozin is associated with a reduced risk for kidney failure and cardiovascular events in people with type 2 diabetes and chronic kidney disease – and discusses how these results will impact clinical practice (6:51).

08-01-2018 | Type 2 diabetes | View from the clinic | Article

Barriers to insulin: Management in type 2 diabetes patients

Editorial Board member Lori Berard discusses how to meet and overcome the challenges that follow the initial insulin prescription in patients with type 2 diabetes (11:53).

06-06-2018 | Insulin | View from the clinic | Article

Barriers to insulin: Initiation in type 2 diabetes patients

Editorial Board member Lori Berard talks through the stages and challenges associated with preparing type 2 diabetes patients for insulin therapy (9:00).

03-19-2018 | Diet | View from the clinic | Article

UK nutrition guidelines: A fresh approach

Board members John Wilding and Pamela Dyson talk about the fresh approach taken to the latest update of the Diabetes UK nutrition guidelines (9:43).

08-22-2017 | Canagliflozin | Podcast | Article

Dissecting the CANVAS trial

In this podcast, CANVAS investigators Carol Wysham and Lori Berard discuss the implications of the program's findings for healthcare professionals treating patients with diabetes (11:17).

Image Credits